Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Avantor, Inc. | EVP, Bioscience Production | Common Stock | 74.1K | $1.28M | $17.30 | Feb 23, 2025 | Direct |
Avantor, Inc. | EVP, Bioscience Production | Stock Options (Right to Buy) | 86.6K | Feb 20, 2025 | Direct | ||
Avantor, Inc. | EVP, Bioscience Production | Stock Options (Right to Buy) | 62.8K | Feb 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVTR | Avantor, Inc. | Feb 20, 2025 | 3 | -$49.2K | 4 | Feb 24, 2025 | EVP, Bioscience Production |
AVTR | Avantor, Inc. | Oct 2, 2024 | 1 | -$32.3K | 4 | Oct 4, 2024 | EVP, Bioscience Production |
AVTR | Avantor, Inc. | Feb 23, 2024 | 2 | $0 | 4 | Feb 27, 2024 | EVP, Biopharma Production |
AVTR | Avantor, Inc. | Oct 2, 2023 | 2 | $0 | 4 | Oct 4, 2023 | EVP, Biopharma Production |
AVTR | Avantor, Inc. | Oct 2, 2023 | 0 | $0 | 3 | Oct 4, 2023 | EVP, Biopharma Production |